Title: Terri Kim - Innovator in Delayed-Release Pharmaceutical Compositions
Introduction
Terri Kim is a notable inventor based in the United States, recognized for her contributions to the field of pharmaceuticals. She has developed innovative compositions aimed at improving the pharmacokinetics of biguanide compounds. Her work focuses on enhancing the efficacy and safety of these medications.
Latest Patents
Terri Kim holds a patent for a Delayed-Release Composition Comprising Biguanide. This invention provides compositions and methods designed to improve the pharmacokinetics and reduce the risk of adverse events associated with biguanide compound administration. The formulation includes delayed-release formulations that feature a lag phase release, which is crucial for optimizing therapeutic outcomes.
Career Highlights
Terri Kim is currently employed at Anji Pharmaceuticals Inc., where she continues to advance her research and development efforts. Her work is pivotal in the pharmaceutical industry, particularly in the area of drug formulation and delivery systems.
Collaborations
Terri collaborates with esteemed colleagues, including Alain D. Baron and Mark S. Fineman, who contribute to her research initiatives and help drive innovation within the company.
Conclusion
Terri Kim's work in developing delayed-release pharmaceutical compositions showcases her commitment to improving patient outcomes through innovative drug delivery methods. Her contributions to the field are significant and reflect her expertise as an inventor.